Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $796.55 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $101.95 | 1 | $0 (2024) |
| PFIZER INC. | $96.79 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $93.58 | 4 | $0 (2024) |
| Abbott Laboratories | $90.46 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $88.91 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $81.79 | 5 | $0 (2021) |
| Merck Sharp & Dohme LLC | $76.07 | 4 | $0 (2024) |
| Medtronic USA, Inc. | $45.83 | 2 | $0 (2017) |
| ABBVIE INC. | $31.26 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $299.03 | 10 | Janssen Scientific Affairs, LLC ($101.95) |
| 2022 | $75.13 | 5 | Janssen Pharmaceuticals, Inc ($42.07) |
| 2021 | $65.89 | 4 | E.R. Squibb & Sons, L.L.C. ($33.59) |
| 2020 | $29.15 | 2 | Janssen Pharmaceuticals, Inc ($15.81) |
| 2019 | $110.14 | 6 | PFIZER INC. ($61.78) |
| 2018 | $143.19 | 4 | Abbott Laboratories ($90.46) |
| 2017 | $74.02 | 4 | Medtronic USA, Inc. ($45.83) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardiology | ||||||
| 08/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: DIABETES | ||||||
| 04/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/16/2024 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $101.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/25/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Cardiovascular | ||||||
| 03/31/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/17/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: Cardiovascular | ||||||
| 01/06/2021 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: VTE | ||||||
| 11/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.34 | General |
| Category: Cardiovascular | ||||||
| 01/24/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/04/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: Cardiovascular | ||||||
| 08/22/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Cardiovascular | ||||||
| 07/17/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 681 | 1,015 | $359,264 | $81,007 |
| 2022 | 8 | 890 | 1,422 | $488,500 | $105,875 |
| 2021 | 9 | 788 | 1,283 | $393,976 | $86,154 |
| 2020 | 8 | 784 | 1,266 | $375,746 | $91,914 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 235 | 498 | $126,204 | $29,954 | 23.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 138 | 140 | $95,680 | $18,389 | 19.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 191 | 193 | $70,285 | $16,386 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 106 | 173 | $63,364 | $15,607 | 24.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $3,731 | $671.01 | 18.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 178 | 387 | $133,088 | $30,217 | 22.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 247 | 561 | $139,640 | $30,105 | 21.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 144 | 145 | $101,993 | $21,354 | 20.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 134 | 137 | $46,464 | $10,978 | 23.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 97 | 99 | $26,980 | $5,229 | 19.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 39 | 39 | $25,501 | $5,166 | 20.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 40 | 40 | $10,011 | $2,070 | 20.7% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 11 | 14 | $4,824 | $756.17 | 15.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 317 | 773 | $180,729 | $42,172 | 23.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 71 | 71 | $50,338 | $10,258 | 20.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 63 | 63 | $39,046 | $8,574 | 22.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 66 | 99 | $40,130 | $7,779 | 19.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 133 | 134 | $35,986 | $7,287 | 20.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 68 | 68 | $20,779 | $5,382 | 25.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 32 | 32 | $10,323 | $1,765 | 17.1% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 24 | 29 | $10,143 | $1,578 | 15.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $6,503 | $1,359 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 308 | 683 | $175,018 | $38,191 | 21.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 121 | 217 | $60,607 | $17,331 | 28.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 79 | 80 | $48,886 | $12,389 | 25.3% |
About Dr. Jitendrakumar Patel, M.D
Dr. Jitendrakumar Patel, M.D is a Hospitalist healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770785727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jitendrakumar Patel, M.D has received a total of $796.55 in payments from pharmaceutical and medical device companies, with $299.03 received in 2024. These payments were reported across 35 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($796.55).
As a Medicare-enrolled provider, Patel has provided services to 3,143 Medicare beneficiaries, totaling 4,986 services with total Medicare billing of $364,950. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Augusta, GA
- Active Since 06/01/2007
- Last Updated 07/11/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1770785727
Products in Payments
- XARELTO (Drug) $190.86
- ELIQUIS (Drug) $178.58
- HeartMate 3 Left Ventricular Dev (Device) $90.46
- ENTRESTO (Drug) $69.86
- VERQUVO (Drug) $59.01
- KYPHON Balloon Kyphoplasty (Device) $45.83
- TEFLARO (Drug) $44.76
- LEQVIO (Drug) $23.72
- JARDIANCE (Drug) $23.46
- FUROSCIX (Drug) $18.94
- LifeVest (Device) $17.72
- CUBICIN RF (Drug) $17.06
- FLOWTRIEVER CATHETER, S (Device) $16.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Augusta
Dr. Tarak Patel, M.d, M.D
Hospitalist — Payments: $36,935
Bret Stysly, M.d, M.D
Hospitalist — Payments: $7,888
Christopher Maiona, M.d, M.D
Hospitalist — Payments: $2,669
Hetal Thakore, Md, MD
Hospitalist — Payments: $1,527
Mohammed Al-Nufal, Md, MD
Hospitalist — Payments: $1,241
Mallika Devarapalli, D.o, D.O
Hospitalist — Payments: $1,128